Venture Capital

ProCertus BioPharm, an oncology-based pharmaceutical company, has closed on a $2.3 million stock financing led by Venture Investors. ProCertus develops therapeutics to protect cancer patients against the side effects of chemotherapy and radiotherapy, and will use the financing to begin clinical trials on cancer patients. ...

TomoTherapy, a medical systems manufacturer spun out of research at the University of Wisconsin-Madison, has raised $223 million in an initial public offering that concluded on May 9. The Madison-based company will use the proceeds to ramp up its global sales and marketing initiatives and...

The Wisconsin delegation hit the ground running at BIO 2007, an international conference for the biotechnology industry. Among the significant news generated at BIO was the announcement by Mark Underwood, president of Quincy Biosciences, that the company has developed a preclinical compound for the...

Mason Wells is spinning off its venture capital business, but the move hardly spells doom for Wisconsin's attempts to generate more venture capital. Mason Wells Venture Funds will be spun into Broadwell Ventures, which will be managed by Dan Broderick and focus on biotechnology, pharmaceutical,...

How does Wisconsin stack up to the nation's best biotechnology hubs? This week in Boston, the state will have plenty to thump its chest about at the annual Biotechnology Industry Organization (BIO) Convention, writes columnist Tom Still. In this edition of Inside Wisconsin, he...

Any business that offers or sells securities is subject to both state and federal securities laws and regulations. In this 10th component of his Early Stage series, columnist and attorney Joe Boucher breaks down the complex rules and regulations pertaining to federal securities laws....

Wisconsin bioscience companies have positioned themselves as national and international leaders in a range of industries - from molecular diagnostics to medical imaging. In this guest column, Jim Leonhart, executive vice president of the Wisconsin Biotechnology and Medical Device Association, explains how these businesses are...

Mithridion, Inc., a Madison-based developer of drugs to slow the progression of Alzheimer's Disease, has secured a second round of venture funding as it continues to develop a drug candidate that would be used in human trials. The company already has demonstrated the efficacy of...

For companies that are hunting for that sometimes elusive angel or venture capital, it all comes down to the term sheet, according to Private Placements columnist Matt Storms. He devotes the latest installment of this capital raising advice column to the finer points of the...

The technology industry in Dane County saw its largest single-year job increase in recent years, and its ranks grew to 510 businesses, according to the 2007 Greater Madison Area Directory of High-Tech Companies. The annual directory lists technology businesses in 12 industry clusters, and shows...